PATENT CLAIM ANALYSIS

Application Number: 15936515
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["424", "443000"]

Abstract:
Transdermal administration system comprising doxofylline as the active ingredient, for use in the treatment of bronchopulmonary diseases having a broncho-obstructive component.

Claim (Index 17):
A transdermal patch comprising a first supporting polymer barrier layer, a second layer comprising a polymer matrix containing doxofylline, and a third layer comprising the pressure-sensitive adhesive, wherein said sensitive adhesive coprises a polymer selected from the group consisting of polyvinylpyrolidone, polyacrylate, and polyisobutene, and said polymer matrix comprises polymer selected from the group consisting of acrylic polymers, silicone polymers, and styrene block copolymers.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 90.0
- Lexical Diversity: 1.04545
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['16090593', '13064334', '13791460', '12823448', '10631539']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6767069290105827
- 35 USC 102 Novelty (BERT): 0.4744022427812233
- Combined Prediction Score: 0.6564764603876468
- Mean Citation Score: 133.7345128
- Max Citation Score: 161.28572
- Similarity Product: 117.0583552723646

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test